METTL14 and inflammatory bowel disease: Selective deletion of Mettl14 in T cells impairs the induction of naïve T cells into induced Treg cells and leads to spontaneous colitis in mouse models, providing a new tool for investigating inflammatory bowel diseases (IBD) or IBD‐associated malignancy (Lu et al, 2020).